Venture-Backed Startups

0 investors

0 investors

Exodigo maps utilities, foundations, and geotechnical conditions beneath infrastructure projects without excavation, using multi-sensor fusion and AI to produce subsurface maps, insights, and visualizations. It serves infrastructure, transit, and utility teams to reduce underground risk during planning, design, and construction.

10 investors

0 investors

Exodrive provides GPS-based fleet and asset management software with AI-powered driver scoring and accident detection for logistics and transportation companies. The platform monitors vehicle location in real-time, analyzes driving behavior, and automatically alerts dispatchers to incidents using machine learning trained on hundreds of billions of kilometers and hundreds of thousands of accident records.

1 investor

Exodus is a cryptocurrency wallet application that enables users to securely manage, store, and exchange digital assets across desktop, mobile, and hardware platforms. The product targets mainstream users seeking simplified, user-friendly access to cryptocurrency without technical barriers.

1 investor

Exodys Energy develops UPCYCLE, a proprietary technology that recycles spent nuclear fuel into secure domestic feedstock for use in today's and next-generation reactors. The company operates with a focus on closing the nuclear fuel cycle through profitable, modular commercial infrastructure.

1 investor

ExoFlare builds a biosecurity platform designed to help intensive animal and food production operations manage disease risks and maintain market access during livestock disease events.

1 investor

éXō Fleets is a fleet ERP and master data platform for mixed-fuel, mixed-class and multi-site fleet operators, unifying data on vehicles, fuels, depots, routes and infrastructure. It helps fleets reduce fuel costs and total cost of ownership, plan electrification, and automate sustainability (Scope) reporting.

2 investors

0 investors

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors. It develops cell therapies aimed at cancer treatment by mining the TCR sequence space to identify safe, non-cross-reactive receptors against shared tumor targets.

2 investors

Exogenus develops therapeutic exosomes derived from umbilical cord blood cells to treat autoimmune diseases through immune system rebalancing. The company targets multiple autoimmune disease indications where existing pharmaceutical treatments carry significant side effects.

1 investor

EXOKĒRYX develops semiconductor-based technology for isolation, characterization, and analysis of extracellular vesicles to enable earlier disease and cancer detection in research settings. The company serves biomedical researchers working on disease detection and diagnostics using chip-based sensors and dielectrophoresis technology.

2 investors

exo connects Macs and workstations into a single local inference cluster, automatically discovering devices, mapping network topology, and splitting AI models across device memory to run frontier models on-premises. It exposes standard OpenAI, Claude, Responses, and Ollama-compatible APIs for developers running AI locally without cloud infrastructure.

4 investors

Exolvo Biosciences develops drug delivery technology. The page does not provide sufficient detail about the company's specific products, markets served, or business model beyond the co-founder's background.

1 investor

ExoMatter builds a software platform for materials research and development, providing tools to help scientists discover and evaluate materials faster. Founded in 2022 as a spin-off from the German Aerospace Center (DLR), it serves R&D teams working on new materials.

5 investors

Exonar helps organizations discover and understand the data they hold at scale, enabling them to better protect and manage information assets. The company uses data discovery technology to identify what data exists within organizations, addressing security and compliance challenges.

1 investor

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema. The drug is set to enter Phase IIb clinical trials in 2026.

4 investors

Exonic develops machine learning models trained on biological data to predict gene therapy designs and genomic regulatory patterns, with initial applications in developing targeted treatments for liver cancer.

1 investor

0 investors

Korean startup developing exosome isolation and Raman-based analysis technology for cancer diagnostics.

2 investors

EXO produces protein bars and cricket powder supplements made from acheta (cricket) protein. The products are marketed as nutritional snacks and ingredients for direct consumer purchase.

3 investors

Exordi is an operating system for content production that consolidates campaign management, creator sourcing, collaboration, content delivery, and payments into a single platform. It serves content teams and creators to reduce tool fragmentation and accelerate campaign execution.

1 investor

Exos Aerospace designs and manufactures reusable launch vehicles and advanced cryogenic fuel tank systems for suborbital and orbital missions. The company serves space operators and researchers seeking affordable, environmentally sustainable alternatives to traditional propulsion technologies.

0 investors